bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Data from A High-Throughput Pharmaceutical Screen Identifies Compounds with Specific Toxicity against BRCA2-Deficient Tumors
Authors: Evers Bastiaan , Schut Eva , van der Burg Eline , Braumuller Tanya M. , Egan David A. , Holstege Henne , Edser Pauline , Adams David J. , Wade-Martins Richard , Bouwman Peter , Jonkers Jos
Published: April 2023

Supplementary Data from A High-Throughput Pharmaceutical Screen Identifies Compounds with Specific Toxicity against BRCA2-Deficient Tumors
Data Supplement from CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA
Authors: Riccardo Federica , Iussich Selina , Maniscalco Lorella , Lorda Mayayo Saray , La Rosa Giuseppe , Arigoni Maddalena , De Maria Raffaella , Gattino Francesca , Lanzardo Stefania , Lardone Elena , Martano Marina , Morello Emanuela , Prestigio Simone , Fiore Alessandra , Quaglino Elena , Zabarino Sara , Ferrone Soldano , Buracco Paolo , Cavallo Federica
Published: April 2023

Supplementary Figure S1. T cell-mediated IFN-γ response induced by hCSPG4 DNA vaccination. Supplementary Figure S2. CSPG4 specific antibody response from each vaccinated dog. Supplementary Figure S3. Effect of CSPG4 specific antibodies induced by vaccination on SK-MEL-28 cell proliferation. Supplementary Figure S4. Anti cCSPG4 specific antibody response induced by vaccination.
Supplementary Table S1. from Relapsed Classic E-Cadherin (CDH1)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations
Authors: Ross Jeffrey S. , Wang Kai , Sheehan Christine E. , Boguniewicz Ann B. , Otto Geoff , Downing Sean R. , Sun James , He Jie , Curran John A. , Ali Siraj , Yelensky Roman , Lipson Doron , Palmer Gary , Miller Vincent A. , Stephens Philip J.
Published: April 2023

Mutant Allele Frequencies of the Mutated Genes in 22 cases of ILC
Supplementary Table 3 from Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis
Authors: Hurst Carolyn D. , Platt Fiona M. , Taylor Claire F. , Knowles Margaret A.
Published: April 2023

PDF file, 59K, Relationship between copy number gains and losses and individual Ta, T1G3 and ≥T2 clusters.
Supplementary Table 1 from [18F]-3′Deoxy-3′-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel
Authors: Contractor Kaiyumars B. , Kenny Laura M. , Stebbing Justin , Rosso Lula , Ahmad Rizvana , Jacob Jimmy , Challapalli Amarnath , Turkheimer Federico , Al-Nahhas Adil , Sharma Rohini , Coombes R. Charles , Aboagye Eric O.
Published: April 2023

PDF file - 61K, SUV in tumors, average and maximum.
Supplementary Figure Legend from Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis
Authors: Hurst Carolyn D. , Platt Fiona M. , Taylor Claire F. , Knowles Margaret A.
Published: April 2023

PDF file, 114K.
Supplementary Figure 4 from Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis
Authors: Hurst Carolyn D. , Platt Fiona M. , Taylor Claire F. , Knowles Margaret A.
Published: April 2023

PDF file, 123K, Copy number (CN), mutation status (MS), loss of heterozygosity analysis (LOH) and immunohistochemistry (IHC) data for all tumors (n=160).
CCR Translation for This Article from BRCA2 Deep Intronic Mutation Causing Activation of a Cryptic Exon: Opening toward a New Preventive Therapeutic Strategy
Authors: Anczuków Olga , Buisson Monique , Léoné Mélanie , Coutanson Christine , Lasset Christine , Calender Alain , Sinilnikova Olga M. , Mazoyer Sylvie
Published: April 2023

CCR Translation for This Article from BRCA2 Deep Intronic Mutation Causing Activation of a Cryptic Exon: Opening toward a New Preventive Therapeutic Strategy
Supplementary Figure 2 from Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis
Authors: Hurst Carolyn D. , Platt Fiona M. , Taylor Claire F. , Knowles Margaret A.
Published: April 2023

PDF file, 1045K, 8q22.2-q22.3 amplification in UC.
Supplementary Figure 1 from Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis
Authors: Hurst Carolyn D. , Platt Fiona M. , Taylor Claire F. , Knowles Margaret A.
Published: April 2023

PDF file, 1713K, Fraction of genome altered (FGA%).
Supplementary Tables 1-5 from IL-10 Promotes Tumor Aggressiveness via Upregulation of CIP2A Transcription in Lung Adenocarcinoma
Authors: Sung Wen-Wei , Wang Yao-Chen , Lin Po-Lin , Cheng Ya-Wen , Chen Chih-Yi , Wu Tzu-Chin , Lee Huei
Published: April 2023

Supplementary Tables 1-5 - PDF file 88K, Supplementary Table 1. List of primer sequences used in the present study; Supplementary Table 2. Univariate analysis of the influence of various clinical parameters, IL-10 mRNA and CIP2A mRNA levels on overall survival in lung adenocarcinoma patients; Supplementary Table 3. The correlation of IL-10 mRNA levels with HPV E6 immunostaining and CIP2A mRNA levels in tumor tissues from lung adenocarcinoma patients; Supplementary Table 4. Multivariate analysis of the influence of IL-10 and CIP2A mRNA on overall survival in HPV DNA positive lung adenocarcinoma patient
Supplementary Figures 3 and 4 from IL-10 Promotes Tumor Aggressiveness via Upregulation of CIP2A Transcription in Lung Adenocarcinoma
Authors: Sung Wen-Wei , Wang Yao-Chen , Lin Po-Lin , Cheng Ya-Wen , Chen Chih-Yi , Wu Tzu-Chin , Lee Huei
Published: April 2023

Supplementary Figures 3 and 4 - PDF file 262K, S3: Exogenous IL-10 regulates tumor migration capability of lung cancer cells; S4: The migration and invasion ability of TL1 cells was decreased in IL-10R knock down stable clone
Supplementary Tables 1-4, Figure 1-2 from Modeling the Transcriptional Consequences of Epidermal Growth Factor Receptor Ablation in Ras-Initiated Squamous Cancer
Authors: Wright Lisa Nolan , Ryscavage Andrew , Merlino Glenn , Yuspa Stuart H.
Published: April 2023

PDF file - 255K
Supplementary Figure Legends from IL-10 Promotes Tumor Aggressiveness via Upregulation of CIP2A Transcription in Lung Adenocarcinoma
Authors: Sung Wen-Wei , Wang Yao-Chen , Lin Po-Lin , Cheng Ya-Wen , Chen Chih-Yi , Wu Tzu-Chin , Lee Huei
Published: April 2023

Supplementary Figure Legends - PDF file 57K, Supplementary Figure Legends
Supplementary Table Legends 1-4, Figure Legends 1-2 from Modeling the Transcriptional Consequences of Epidermal Growth Factor Receptor Ablation in Ras-Initiated Squamous Cancer
Authors: Wright Lisa Nolan , Ryscavage Andrew , Merlino Glenn , Yuspa Stuart H.
Published: April 2023

PDF file - 81K
Supplementary Figure 1 from IL-10 Promotes Tumor Aggressiveness via Upregulation of CIP2A Transcription in Lung Adenocarcinoma
Authors: Sung Wen-Wei , Wang Yao-Chen , Lin Po-Lin , Cheng Ya-Wen , Chen Chih-Yi , Wu Tzu-Chin , Lee Huei
Published: April 2023

Supplementary Figure 1 - PDF file 36K, Doubling time of IL-10-knockdown TL1 cells and IL-10-overexpressing TL4 cells and the error bars represent the S.D. of triplicate results
Supplementary Table 1 from Targeting Fibroblast Growth Factor Receptor Signaling Inhibits Prostate Cancer Progression
Authors: Feng Shu , Shao Longjiang , Yu Wendong , Gavine Paul , Ittmann Michael
Published: April 2023

PDF file, 34KB, Primer sequences.
Supplementary Figure 1 from Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer
Authors: Stearns Vered , Jacobs Lisa K. , Fackler MaryJo , Tsangaris Theodore N. , Rudek Michelle A. , Higgins Michaela , Lange Julie , Cheng Zandra , Slater Shannon A. , Jeter Stacie C. , Powers Penny , Briest Susanne , Chao Calvin , Yoshizawa Carl , Sugar Elizabeth , Espinoza-Delgado Igor , Sukumar Saraswati , Gabrielson Edward , Davidson Nancy E.
Published: April 2023

PDF file, 85K - Supplementary Figure 1 Pre and Post Vorinostat Values of Other Gene Expression using the Oncotype DX 21-gene Assay.
Supplementary Figure Legend from Targeting Fibroblast Growth Factor Receptor Signaling Inhibits Prostate Cancer Progression
Authors: Feng Shu , Shao Longjiang , Yu Wendong , Gavine Paul , Ittmann Michael
Published: April 2023

PDF file, 60KB.
Supplementary Figure 3 from Targeting Fibroblast Growth Factor Receptor Signaling Inhibits Prostate Cancer Progression
Authors: Feng Shu , Shao Longjiang , Yu Wendong , Gavine Paul , Ittmann Michael
Published: April 2023

PDF file, 954KB, Treatment with AZ8010 does not inhibit AKT phosphorylation.
Supplementary Figure 2 from Targeting Fibroblast Growth Factor Receptor Signaling Inhibits Prostate Cancer Progression
Authors: Feng Shu , Shao Longjiang , Yu Wendong , Gavine Paul , Ittmann Michael
Published: April 2023

PDF file, 223KB, Ki67 and CD31 immunohistochemistry and TUNEL of VCaP tumors from mice treated with AZ8010 or vehicle only.
Supplementary Figure 1 from Targeting Fibroblast Growth Factor Receptor Signaling Inhibits Prostate Cancer Progression
Authors: Feng Shu , Shao Longjiang , Yu Wendong , Gavine Paul , Ittmann Michael
Published: April 2023

PDF file, 188KB, AZ8010 inhibits VCaP proliferation and increases apoptosis.
Supplementary Methods from Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma
Authors: Lee Sun Joo , Ghosh Sukhen C. , Han Hee Dong , Stone Rebecca L. , Bottsford-Miller Justin , Shen De Yue , Auzenne Edmond J. , Lopez-Araujo Alejandro , Lu Chunhua , Nishimura Masato , Pecot Chad V. , Zand Behrouz , Thanapprapasr Duangmani , Jennings Nicholas B , Kang Yu , Huang Jie , Hu Wei , Klostergaard Jim , Sood Anil K.
Published: April 2023

PDF file, 108KB.
Supplementary Figure S6 from Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma
Authors: Nadal Ernest , Chen Guoan , Gallegos Marc , Lin Lin , Ferrer-Torres Daysha , Truini Anna , Wang Zhuwen , Lin Jules , Reddy Rishindra M. , Llatjos Roger , Escobar Ignacio , Moya Juan , Chang Andrew C. , Cardenal Felipe , Capellà Gabriel , Beer David G.
Published: April 2023

PDF file 160K, Characterization of miR-34b/c transfectants
Supplementary Table 2 from Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer
Authors: Terashima Masanori , Kitada Koji , Ochiai Atsushi , Ichikawa Wataru , Kurahashi Issei , Sakuramoto Shinichi , Katai Hitoshi , Sano Takeshi , Imamura Hiroshi , Sasako Mitsuru
Published: April 2023

PDF file - 97K, Gene list of biomarkers for assessment
Supplementary Table 1 from Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer
Authors: Terashima Masanori , Kitada Koji , Ochiai Atsushi , Ichikawa Wataru , Kurahashi Issei , Sakuramoto Shinichi , Katai Hitoshi , Sano Takeshi , Imamura Hiroshi , Sasako Mitsuru
Published: April 2023

PDF file - 97K, Characteristics of the Patients According to the Status of EGFR
Supplementary Figure S3 from Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma
Authors: Nadal Ernest , Chen Guoan , Gallegos Marc , Lin Lin , Ferrer-Torres Daysha , Truini Anna , Wang Zhuwen , Lin Jules , Reddy Rishindra M. , Llatjos Roger , Escobar Ignacio , Moya Juan , Chang Andrew C. , Cardenal Felipe , Capellà Gabriel , Beer David G.
Published: April 2023

PDF file 68K, Frequency of miR-34b/c promoter methylation and correlation of tumors miR-34b/c expression with methylation status
Supplementary Figure 4 from Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer
Authors: Terashima Masanori , Kitada Koji , Ochiai Atsushi , Ichikawa Wataru , Kurahashi Issei , Sakuramoto Shinichi , Katai Hitoshi , Sano Takeshi , Imamura Hiroshi , Sasako Mitsuru
Published: April 2023

PDF file - 67K, Kaplan-Meier curves for OS of all patients (n = 829) according to EGFR score
Supplementary Figure S2 from Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma
Authors: Nadal Ernest , Chen Guoan , Gallegos Marc , Lin Lin , Ferrer-Torres Daysha , Truini Anna , Wang Zhuwen , Lin Jules , Reddy Rishindra M. , Llatjos Roger , Escobar Ignacio , Moya Juan , Chang Andrew C. , Cardenal Felipe , Capellà Gabriel , Beer David G.
Published: April 2023

PDF file 167K, Restoration of miR-34b/c expression by treating lung AC cell lines with 5-Aza-2'-Deoxycytidine
Supplementary Figure Legends 1-4 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
Authors: Manfredi Mark G. , Ecsedy Jeffrey A. , Chakravarty Arijit , Silverman Lee , Zhang Mengkun , Hoar Kara M. , Stroud Stephen G. , Chen Wei , Shinde Vaishali , Huck Jessica J. , Wysong Deborah R. , Janowick David A. , Hyer Marc L. , LeRoy Patrick J. , Gershman Rachel E. , Silva Matthew D. , Germanos Melissa S. , Bolen Joseph B. , Claiborne Christopher F. , Sells Todd B.
Published: April 2023

PDF file - 27K
Supplementary Figure Legend from Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
Authors: Zhang Liling , Riethdorf Sabine , Wu Gang , Wang Tao , Yang Kunyu , Peng Gang , Liu Junli , Pantel Klaus
Published: April 2023

PDF file, 58K.
Supplementary Figure 1 from Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
Authors: Zhang Liling , Riethdorf Sabine , Wu Gang , Wang Tao , Yang Kunyu , Peng Gang , Liu Junli , Pantel Klaus
Published: April 2023

PDF file, 333K, Funnel plots of the hazard ratio (HR) for survival.
Supplementary Table 3 from Brachyury, a Driver of the Epithelial–Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer
Authors: Roselli Mario , Fernando Romaine I. , Guadagni Fiorella , Spila Antonella , Alessandroni Jhessica , Palmirotta Raffaele , Costarelli Leopoldo , Litzinger Mary , Hamilton Duane , Huang Bruce , Tucker Joanne , Tsang Kwong-Yok , Schlom Jeffrey , Palena Claudia
Published: April 2023

PDF file, 113KB, Patient characteristics for samples in human lung cancer cDNA arrays.
Supplementary Figure 2 from Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer
Authors: Sangai Takafumi , Akcakanat Argun , Chen Huiqin , Tarco Emily , Wu Yun , Do Kim-Anh , Miller Todd W. , Arteaga Carlos L. , Mills Gordon B. , Gonzalez-Angulo Ana Maria , Meric-Bernstam Funda
Published: April 2023

PDF file, 66K, MK-2206 treatment in vivo.
Supplementary Figure 1 from Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer
Authors: Sangai Takafumi , Akcakanat Argun , Chen Huiqin , Tarco Emily , Wu Yun , Do Kim-Anh , Miller Todd W. , Arteaga Carlos L. , Mills Gordon B. , Gonzalez-Angulo Ana Maria , Meric-Bernstam Funda
Published: April 2023

PDF file, 45K, Comparison of values of mutant and wild-type cell lines.
Supplementary Figure Legend from Antitumor Activity of Targeted and Cytotoxic Agents in Murine Subcutaneous Tumor Models Correlates with Clinical Response
Authors: Wong Harvey , Choo Edna F. , Alicke Bruno , Ding Xiao , La Hank , McNamara Erin , Theil Frank-Peter , Tibbitts Jay , Friedman Lori S. , Hop Cornelis E.C.A. , Gould Stephen E.
Published: April 2023

PDF file, 50KB.
Supplementary Figure Legends from Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer
Authors: Spreafico Anna , Tentler John J. , Pitts Todd M. , Tan Aik Choon , Gregory Mark A. , Arcaroli John J. , Klauck Peter J. , McManus Martine C. , Hansen Ryan J. , Kim Jihye , Micel Lindsey N. , Selby Heather M. , Newton Timothy P. , McPhillips Kelly L. , Gustafson Daniel L. , DeGregori James V. , Messersmith Wells A. , Winn Robert A. , Eckhardt S. Gail
Published: April 2023

Supplementary Figure Legends - PDF file 100K, Supplementary Figure Legends
Supplementary Figure Legend from Defective Epidermal Innate Immunity and Resultant Superficial Dermatophytosis in Adult T-cell Leukemia/Lymphoma
Authors: Sawada Yu , Nakamura Motonobu , Kabashima-Kubo Rieko , Shimauchi Takatoshi , Kobayashi Miwa , Tokura Yoshiki
Published: April 2023

PDF file, 98KB.
Supplementary Tables 2 - 4 from HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
Authors: Li Ling , Tang Wenhua , Wu Xiaoqing , Karnak David , Meng Xiaojie , Thompson Rachel , Hao Xinbao , Li Yongmin , Qiao Xiaotan T. , Lin Jiayuh , Fuchs James , Simeone Diane M. , Chen Zhi-Nan , Lawrence Theodore S. , Xu Liang
Published: April 2023

PDF file - 173K, Association of the HAb18G/CD147 expression with, and correlation between HAb18G/CD147-CD44s-pSTAT3 co-expression and the clinicopathologic factors (related to Figure 5B-C).
Supplementary Figure 3 from Costimulatory Protein 4IgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness
Authors: Lemke Dieter , Pfenning Philipp-Niclas , Sahm Felix , Klein Ann-Catherine , Kempf Tore , Warnken Uwe , Schnölzer Martina , Tudoran Ruxandra , Weller Michael , Platten Michael , Wick Wolfgang
Published: April 2023

PDF file - 4.2MB
Supplementary Methods and Figures 1 - 5 from A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy
Authors: Ribba Benjamin , Kaloshi Gentian , Peyre Mathieu , Ricard Damien , Calvez Vincent , Tod Michel , Čajavec-Bernard Branka , Idbaih Ahmed , Psimaras Dimitri , Dainese Linda , Pallud Johan , Cartalat-Carel Stéphanie , Delattre Jean-Yves , Honnorat Jérôme , Grenier Emmanuel , Ducray François
Published: April 2023

PDF file, 258K, Figure S 1: Stepwise procedure applied to build the model structure (left panel); non-specific and specific evaluation criteria for model selection (right panel). Figure S 2: Results of the sensitivity analysis for the model on the 21 patients treated with PCV. The analysis consists of repeating the estimations, leaving out one patient's data at a time. Parameter estimates are represented with histograms indicating the number of patients (y-axis) for each value of the parameter (x-axis). It appears that no single patient substantially influenced the estimation. Figure S 3: Comparison of parameter estimates in the 21 patients treated with PCV when the variability of KDE is fixed to 0 or fixed to 70%. Figure S 4: Comparison of parameter estimates between the PCV dataset (n = 21) and the pooled dataset (n = 40, comprising patients from the PCV and radiotherapy datasets). The probability density functions calculated using the standard errors on the estimates are represented in continuous and dashed lines for the PCV and pooled datasets, respectively. They show that with the exception of two treatment-specific parameters (the efficacy parameter γ and the transfer rate from Qp to P, ), the parameters are homogeneous. Figure S 5: MTD observations (symbols) and individual predictions (solid line) for six individuals sampled from the PCV dataset. Included is the 90% confidence interval around the individual predictions obtained by simulations using the standard errors of the empirical Bayes estimates.
Supplementary Figure 1 from Temozolomide-Mediated DNA Methylation in Human Myeloid Precursor Cells: Differential Involvement of Intrinsic and Extrinsic Apoptotic Pathways
Authors: Wang Haiyan , Cai Shanbao , Ernstberger Aaron , Bailey Barbara J. , Wang Michael Z. , Cai Wenjing , Goebel W. Scott , Czader Magdalena B. , Crean Colin , Suvannasankha Attaya , Shokolenkoc Inna , Wilson Glenn L. , Baluyut Arthur R. , Mayo Lindsey D. , Pollok Karen E.
Published: April 2023

PDF file - 2870K, Figure 1 is a detailed characterization of the myeloid precursor cells used in the study.
Related Article from Rehabilitation for Oncogene Addiction: Role of Immunity in Cellular Sobriety
Authors: Bajor David L. , Vonderheide Robert H.
Published: April 2023

Related Article from Rehabilitation for Oncogene Addiction: Role of Immunity in Cellular Sobriety
Supplementary Table 3 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
Authors: Harbst Katja , Staaf Johan , Lauss Martin , Karlsson Anna , Måsbäck Anna , Johansson Iva , Bendahl Pär-Ola , Vallon-Christersson Johan , Törngren Therese , Ekedahl Henrik , Geisler Jürgen , Höglund Mattias , Ringnér Markus , Lundgren Lotta , Jirström Karin , Olsson Håkan , Ingvar Christian , Borg Åke , Tsao Hensin , Jönsson Göran
Published: April 2023

PDF file - 48K, Multi�class SAM analysis revealed 503 probes which were found to significantly differ between the four subtypes in GSE22155 at FDR=0
Supplementary Methods, Figures 3-5 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
Authors: Harbst Katja , Staaf Johan , Lauss Martin , Karlsson Anna , Måsbäck Anna , Johansson Iva , Bendahl Pär-Ola , Vallon-Christersson Johan , Törngren Therese , Ekedahl Henrik , Geisler Jürgen , Höglund Mattias , Ringnér Markus , Lundgren Lotta , Jirström Karin , Olsson Håkan , Ingvar Christian , Borg Åke , Tsao Hensin , Jönsson Göran
Published: April 2023

PDF file - 199K
Supplementary Figure 1 from Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
Authors: Harbst Katja , Staaf Johan , Lauss Martin , Karlsson Anna , Måsbäck Anna , Johansson Iva , Bendahl Pär-Ola , Vallon-Christersson Johan , Törngren Therese , Ekedahl Henrik , Geisler Jürgen , Höglund Mattias , Ringnér Markus , Lundgren Lotta , Jirström Karin , Olsson Håkan , Ingvar Christian , Borg Åke , Tsao Hensin , Jönsson Göran
Published: April 2023

PDF file - 91K, Flow chart describing the analysis
CCR Translation for This Article from Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Authors: Besser Michal J. , Shapira-Frommer Ronnie , Itzhaki Orit , Treves Avraham J. , Zippel Douglas B. , Levy Daphna , Kubi Adva , Shoshani Noa , Zikich Dragoslav , Ohayon Yaara , Ohayon Daniel , Shalmon Bruria , Markel Gal , Yerushalmi Ronit , Apter Sara , Ben-Nun Alon , Ben-Ami Eytan , Shimoni Avichai , Nagler Arnon , Schachter Jacob
Published: April 2023

CCR Translation for This Article from Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Supplementary Table 1 from EGFR Protein Expression in Non–Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor—A Novel Antibody for Immunohistochemistry or AQUA Technology
Authors: Mascaux Celine , Wynes Murry W. , Kato Yasufumi , Tran Cindy , Asuncion Bernadette Reyna , Zhao Jason M. , Gustavson Mark , Ranger-Moore Jim , Gaire Fabien , Matsubayashi Jun , Nagao Toshitaka , Yoshida Koichi , Ohira Tatuso , Ikeda Norihiko , Hirsch Fred R.
Published: April 2023

PDF file - 73KB
Supplementary Figure 3 from Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance
Authors: Ambrosini Grazia , Pratilas Christine A. , Qin Li-Xuan , Tadi Madhavi , Surriga Oliver , Carvajal Richard D. , Schwartz Gary K.
Published: April 2023

PDF file, 1824KB, Effects of PD0325901 on MEK-dependent gene expression and cell viability of uveal melanoma.
Supplementary Figure 2 from A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells
Authors: Puig Isabel , Chicote Irene , Tenbaum Stephan P. , Arqués Oriol , Herance José Raúl , Gispert Juan D. , Jimenez José , Landolfi Stefania , Caci Karina , Allende Helena , Mendizabal Leire , Moreno Debora , Charco Ramón , Espín Eloy , Prat Aleix , Elez Maria Elena , Argilés Guillem , Vivancos Ana , Tabernero Josep , Rojas Santiago , Palmer Héctor G.
Published: April 2023

PDF file - 248K, Distant metastasis generated by cells derived from patient 5.
Supplementary Figure 1 from Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance
Authors: Ambrosini Grazia , Pratilas Christine A. , Qin Li-Xuan , Tadi Madhavi , Surriga Oliver , Carvajal Richard D. , Schwartz Gary K.
Published: April 2023

PDF file, 2055KB, Selumetinib inhibits pERK and induces cell cycle arrest in uveal melanoma.
Supplementary Table 5 from Genomic Estimates of Aneuploid Content in Glioblastoma Multiforme and Improved Classification
Authors: Li Bo , Senbabaoglu Yasin , Peng Weiping , Yang Min-Lee , Xu Jishu , Li Jun Z.
Published: April 2023

XLS file, 457K, List of 651 genes chosen as top markers for distinguising the three non-Proneural subtypes.
Supplementary Figure Legend from Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features
Authors: Gammaitoni Loretta , Giraudo Lidia , Leuci Valeria , Todorovic Maja , Mesiano Giulia , Picciotto Franco , Pisacane Alberto , Zaccagna Alessandro , Volpe Maria Giuseppa , Gallo Susanna , Caravelli Daniela , Giacone Elena , Venesio Tiziana , Balsamo Antonella , Pignochino Ymera , Grignani Giovanni , Carnevale-Schianca Fabrizio , Aglietta Massimo , Sangiolo Dario
Published: April 2023

PDF file - 64K
Supplementary Figure 6 from Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features
Authors: Gammaitoni Loretta , Giraudo Lidia , Leuci Valeria , Todorovic Maja , Mesiano Giulia , Picciotto Franco , Pisacane Alberto , Zaccagna Alessandro , Volpe Maria Giuseppa , Gallo Susanna , Caravelli Daniela , Giacone Elena , Venesio Tiziana , Balsamo Antonella , Pignochino Ymera , Grignani Giovanni , Carnevale-Schianca Fabrizio , Aglietta Massimo , Sangiolo Dario
Published: April 2023

PDF file - 117K, Expression level of ABCG2 (a), NKG2D ligands MIC A/B (b) and ULBP2 (c) in LV-oct4-eGFP transduced cells.
Supplementary Figure 1 from Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features
Authors: Gammaitoni Loretta , Giraudo Lidia , Leuci Valeria , Todorovic Maja , Mesiano Giulia , Picciotto Franco , Pisacane Alberto , Zaccagna Alessandro , Volpe Maria Giuseppa , Gallo Susanna , Caravelli Daniela , Giacone Elena , Venesio Tiziana , Balsamo Antonella , Pignochino Ymera , Grignani Giovanni , Carnevale-Schianca Fabrizio , Aglietta Massimo , Sangiolo Dario
Published: April 2023

PDF file - 143K, Primary melanoma cell targets.
Supplementary Figure 6 from Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts
Authors: Tate Sonya C. , Cai Shufen , Ajamie Rose T. , Burke Teresa , Beckmann Richard P. , Chan Edward M. , De Dios Alfonso , Wishart Graham N. , Gelbert Lawrence M. , Cronier Damien M.
Published: April 2023

PDF file - 350KB, Model simulations of tumor size dynamics for 17 days of growth followed by a 21-day daily dosing regimen of 25, 50 and 100 mg/kg of LY2835219 for the full model (green line) or for the model incorporating tumor growth inhibition by cell cycle arrest alone (blue line), compared to control tumor growth (red line).
Supplementary Figure 5 from Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts
Authors: Tate Sonya C. , Cai Shufen , Ajamie Rose T. , Burke Teresa , Beckmann Richard P. , Chan Edward M. , De Dios Alfonso , Wishart Graham N. , Gelbert Lawrence M. , Cronier Damien M.
Published: April 2023

PDF file - 22KB, Model simulated dose response curve for the average (red line), minimum (green line) and maximum (blue line) levels of p-Rb and pHH3 over a 24 period at steady state following daily dosing.
Supplementary Figure 1 from Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts
Authors: Tate Sonya C. , Cai Shufen , Ajamie Rose T. , Burke Teresa , Beckmann Richard P. , Chan Edward M. , De Dios Alfonso , Wishart Graham N. , Gelbert Lawrence M. , Cronier Damien M.
Published: April 2023

PDF file - 349KB, External validation of the PK model by VPC in colo-205 xenograft bearing mice receiving a single 6.25, 12.5, 25 and 50 mg/kg oral dose of LY2835219, or with oral doses of 50 and 100 mg/kg administered daily for 21 days.
Supplementary Material 2 from The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel
Authors: Pasche Nadine , Wulhfard Sarah , Pretto Francesca , Carugati Elisa , Neri Dario
Published: April 2023

PDF file, 52KB, Supplementary Material 2. Mean, median and 95% Confidence Intervals for therapy groups.
Supplementary Material 1 from The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel
Authors: Pasche Nadine , Wulhfard Sarah , Pretto Francesca , Carugati Elisa , Neri Dario
Published: April 2023

PDF file, 109 KB, Supplementary Material 1. Materials and methods. (S1.1) Cell culture conditions. (S1.2) Cloning of fusion proteins.
Supplementary Material from Developing Standards for Breakthrough Therapy Designation in Oncology
Authors: Horning Sandra J. , Haber Daniel A. , Selig Wendy K.D. , Ivy S. Percy , Roberts Samantha A. , Allen Jeff D. , Sigal Ellen V. , Sawyers Charles L.
Published: April 2023

Supplementary Material: Case Studies of Recent Therapeutic Breakthroughs PDF file 98K, This describes four recent breakthroughs (3 in oncology and 1 in cystic fibrosis)
Supplementary Figure 6 from Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone
Authors: Ryan Charles J. , Rosenthal Mark , Ng Siobhan , Alumkal Joshi , Picus Joel , Gravis Gwenaëlle , Fizazi Karim , Forget Frédéric , Machiels Jean-Pascal , Srinivas Sandy , Zhu Min , Tang Rui , Oliner Kelly S. , Jiang Yizhou , Loh Elwyn , Dubey Sarita , Gerritsen Winald R.
Published: April 2023

PDF file - 28K, Kaplan-Meier plot of OS (A) and PFS (B) by tumor MET expression in all treatment arms combined.
Supplementary Figure 5 from Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone
Authors: Ryan Charles J. , Rosenthal Mark , Ng Siobhan , Alumkal Joshi , Picus Joel , Gravis Gwenaëlle , Fizazi Karim , Forget Frédéric , Machiels Jean-Pascal , Srinivas Sandy , Zhu Min , Tang Rui , Oliner Kelly S. , Jiang Yizhou , Loh Elwyn , Dubey Sarita , Gerritsen Winald R.
Published: April 2023

PDF file - 28K, Waterfall plot of the maximum change in the sum of the longest diameters of tumors from baseline in patients with evaluable tumor response per investigator assessment who received rilotumumab (A) or placebo (B). Fifteen patients in the rilotumumab group and five patients in the placebo group were omitted because post-baseline data were not available. PD, progressive disease; SD, stable disease; UE, unevaluable.
Supplementary Figure 1 from A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients
Authors: Eechoute Karel , Fransson Martin N. , Reyners An K. , de Jong Floris A. , Sparreboom Alex , van der Graaf Winette T.A. , Friberg Lena E. , Schiavon Gaia , Wiemer Erik A.C. , Verweij Jaap , Loos Walter J. , Mathijssen Ron H.J. , De Giorgi Ugo
Published: April 2023

PDF file, 104K, A: Digital Imaging and Communications in Medicine (DICOM) files were imported in OsiriX Imaging Software for MacOS X (OsiriX Foundation, Geneva, Switserland). Metastatic liver lesions were then drawn as areas of interest with the pencil selection tool. B: Volumes of 3-dimensional structures were automatically calculated by OsiriX Imaging Software.
CCR Translation for This Article from A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients
Authors: Eechoute Karel , Fransson Martin N. , Reyners An K. , de Jong Floris A. , Sparreboom Alex , van der Graaf Winette T.A. , Friberg Lena E. , Schiavon Gaia , Wiemer Erik A.C. , Verweij Jaap , Loos Walter J. , Mathijssen Ron H.J. , De Giorgi Ugo
Published: April 2023

CCR Translation for This Article from A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients
Supplementary Figure S2 from Potent Antimyeloma Activity of a Novel ERK5/CDK Inhibitor
Authors: Álvarez-Fernández Stela , Ortiz-Ruiz María Jesús , Parrott Tracy , Zaknoen Sara , Ocio Enrique M. , San Miguel Jesús , Burrows Francis J. , Esparís-Ogando Azucena , Pandiella Atanasio
Published: April 2023

Action of TG02 on the in vivo growth of OPM-2-derived plasmocytomas.
Supplementary Materials from Antibiotic Treatment Decreases Microbial Burden Associated with Pseudomyxoma Peritonei and Affects β-Catenin Distribution
Authors: Semino-Mora Cristina , Testerman Traci L. , Liu Hui , Whitmire Jeannette M. , Studeman Kimberley , Jia Yali , McAvoy Thomas J. , Francis Jennifer , Nieroda Carol , Sardi Armando , Merrell D. Scott , Dubois Andre
Published: April 2023

Supplementary Materials - PDF file 297K, Additional methods for studies described within the manuscript
Live Dead Staining Figure S1 from Antibiotic Treatment Decreases Microbial Burden Associated with Pseudomyxoma Peritonei and Affects β-Catenin Distribution
Authors: Semino-Mora Cristina , Testerman Traci L. , Liu Hui , Whitmire Jeannette M. , Studeman Kimberley , Jia Yali , McAvoy Thomas J. , Francis Jennifer , Nieroda Carol , Sardi Armando , Merrell D. Scott , Dubois Andre
Published: April 2023

Live Dead Staining Figure S1 - PDF file 142K, Live Dead Staining of bacteria
Related Article from For Breast Cancer Prognosis, Immunoglobulin Kappa Chain Surfaces to the Top
Authors: Whiteside Theresa L. , Ferrone Soldano
Published: April 2023

Related Article from For Breast Cancer Prognosis, Immunoglobulin Kappa Chain Surfaces to the Top
Supplementary Figure 2 from IGKV3 Proteins as Candidate “Off-the-Shelf” Vaccines for Kappa-Light Chain–Restricted B-Cell Non-Hodgkin Lymphomas
Authors: Martorelli Debora , Guidoboni Massimo , De Re Valli , Muraro Elena , Turrini Riccardo , Merlo Anna , Pasini Elisa , Caggiari Laura , Romagnoli Luca , Spina Michele , Mortarini Roberta , Gasparotto Daniela , Mazzucato Mario , Carbone Antonino , Rosato Antonio , Anichini Andrea , Dolcetti Riccardo
Published: April 2023

PDF file, 331KB, Cross-reactive CTL responses elicited by native IGKV3-20 epitopes.
Supplementary Figures 1 - 2, Tables 1 - 4 from Prognostic Significance of Promoter DNA Methylation in Patients with Childhood Neuroblastoma
Authors: Lau Diana T. , Hesson Luke B. , Norris Murray D. , Marshall Glenn M. , Haber Michelle , Ashton Lesley J.
Published: April 2023

PDF file, 415K, Representative CoBRA and bisulfite sequencing results are shown in Supplementary Figure S1-S2. PCR conditions for CoBRA and bisulfite sequencing are listed in Supplementary Table S1 and S2. Clinical characteristics of the study population is presented in Supplementary Table S3. Representative GoldenGate and CoBRA results are shown in Supplementary Table S4.
Supplementary Table 1 from The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal Mucosa
Authors: Gaedcke Jochen , Grade Marian , Camps Jordi , Søkilde Rolf , Kaczkowski Bogumil , Schetter Aaron J. , Difilippantonio Michael J. , Harris Curtis C. , Ghadimi B. Michael , Møller Søren , Beissbarth Tim , Ried Thomas , Litman Thomas
Published: April 2023

XLSX file, 64K, Clinical data.
Supplementary Figure 2 from The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal Mucosa
Authors: Gaedcke Jochen , Grade Marian , Camps Jordi , Søkilde Rolf , Kaczkowski Bogumil , Schetter Aaron J. , Difilippantonio Michael J. , Harris Curtis C. , Ghadimi B. Michael , Møller Søren , Beissbarth Tim , Ried Thomas , Litman Thomas
Published: April 2023

PDF file, 164K, Lack of correlation between array and qRT-PCR data for two miRNAs.
Supplementary Figure 7 from Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Authors: Di Martino Maria T. , Leone Emanuela , Amodio Nicola , Foresta Umberto , Lionetti Marta , Pitari Maria R. , Cantafio Maria E. Gallo , Gullà Annamaria , Conforti Francesco , Morelli Eugenio , Tomaino Vera , Rossi Marco , Negrini Massimo , Ferrarini Manlio , Caraglia Michele , Shammas Masood A. , Munshi Nikhil C. , Anderson Kenneth C. , Neri Antonino , Tagliaferri Pierosandro , Tassone Pierfrancesco
Published: April 2023

PDF file - 106K, Systemic delivery of formulated miR34a mimics affects the growth of MM xenografts
Supplementary Figure 3 from IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
Authors: Wainwright Derek A. , Balyasnikova Irina V. , Chang Alan L. , Ahmed Atique U. , Moon Kyung-Sub , Auffinger Brenda , Tobias Alex L. , Han Yu , Lesniak Maciej S.
Published: April 2023

PDF file, 370K, Brain tumor derived IDO and peripheral Tregs.
Supplementary Figure 2 from IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
Authors: Wainwright Derek A. , Balyasnikova Irina V. , Chang Alan L. , Ahmed Atique U. , Moon Kyung-Sub , Auffinger Brenda , Tobias Alex L. , Han Yu , Lesniak Maciej S.
Published: April 2023

PDF file, 84K, Correlation of patient characteristics with IDO expression.
Supplementary Figure 1 from IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
Authors: Wainwright Derek A. , Balyasnikova Irina V. , Chang Alan L. , Ahmed Atique U. , Moon Kyung-Sub , Auffinger Brenda , Tobias Alex L. , Han Yu , Lesniak Maciej S.
Published: April 2023

PDF file, 477K, mRNA and protein expression of IDO.
Supplementary Figure 1 from Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Authors: Di Martino Maria T. , Leone Emanuela , Amodio Nicola , Foresta Umberto , Lionetti Marta , Pitari Maria R. , Cantafio Maria E. Gallo , Gullà Annamaria , Conforti Francesco , Morelli Eugenio , Tomaino Vera , Rossi Marco , Negrini Massimo , Ferrarini Manlio , Caraglia Michele , Shammas Masood A. , Munshi Nikhil C. , Anderson Kenneth C. , Neri Antonino , Tagliaferri Pierosandro , Tassone Pierfrancesco
Published: April 2023

PDF file - 70K, miR-34a transfection of MM cell lines
CCR Translation for This Article from IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
Authors: Wainwright Derek A. , Balyasnikova Irina V. , Chang Alan L. , Ahmed Atique U. , Moon Kyung-Sub , Auffinger Brenda , Tobias Alex L. , Han Yu , Lesniak Maciej S.
Published: April 2023

CCR Translation for This Article from IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
Related Article from Double Down for a Double Win
Authors: Huang Pearl S.
Published: April 2023

Related Article from Double Down for a Double Win
Supplementary Methods from A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors
Authors: Hong David S. , Bowles Daniel W. , Falchook Gerald S. , Messersmith Wells A. , George Goldy C. , O'Bryant Cindy L. , Vo Alex C. H. , Klucher Kevin , Herbst Roy S. , Eckhardt S. Gail , Peterson Scott , Hausman Diana F. , Kurzrock Razelle , Jimeno Antonio
Published: April 2023

PDF file, 84KB.
Supplementary Figures 1-4 from Important Role of Caspase-8 for Chemosensitivity of ALL Cells
Authors: Ehrhardt Harald , Wachter Franziska , Maurer Martina , Stahnke Karsten , Jeremias Irmela
Published: April 2023

PDF file - 631K
Supplementary Figure 1 from Prolonged Inhibition of Glioblastoma Xenograft Initiation and Clonogenic Growth following In Vivo Notch Blockade
Authors: Chu Qian , Orr Brent A. , Semenkow Samantha , Bar Eli E. , Eberhart Charles G.
Published: April 2023

PDF file - 54K, MRK003 slows growth of HSR-GBM1 XG2 glioblastoma xenografts.
Supplementary Figure 3 from Combined Alloreactive CTL Cellular Therapy with Prodrug Activator Gene Therapy in a Model of Breast Cancer Metastatic to the Brain
Authors: Hickey Michelle J. , Malone Colin C. , Erickson Kate L. , Lin Amy , Soto Horacio , Ha Edward T. , Kamijima Shuichi , Inagaki Akihito , Takahashi Masamichi , Kato Yuki , Kasahara Noriyuki , Mueller Barbara M. , Kruse Carol A.
Published: April 2023

PDF file - 1480K, Clinical study design formulated for immunogene therapy of brain metastases.
Supplementary Methods, Figures 1-3 from Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507
Authors: Fleuren Emmy D.G. , Versleijen-Jonkers Yvonne M.H. , van de Luijtgaarden Addy C.M. , Molkenboer-Kuenen Janneke D.M. , Heskamp Sandra , Roeffen Melissa H.S. , van Laarhoven Hanneke W.M. , Houghton Peter J. , Oyen Wim J.G. , Boerman Otto C. , van der Graaf Winette T.A.
Published: April 2023

PDF file - 2.8MB
Supplementary Table 3 from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
Authors: Alfonso Sailyn , Valdés-Zayas Anet , Santiesteban Eduardo R. , Flores Yoanna I. , Areces Fernando , Hernández Maurenis , Viada Carmen E. , Mendoza Ivis C. , Guerra Pedro P. , García Elena , Ortiz Ramón A. , de la Torre Ana V. , Cepeda Meylán , Pérez Kirenia , Chong Eric , Hernández Ana María , Toledo Darien , González Zuyén , Mazorra Zaima , Crombet Tania , Pérez Rolando , Vázquez Ana María , Macías Amparo E.
Published: April 2023

PDF file - 132KB, Number of doses received, maximal titer and isotype analysis against Racotumomab-mAb and NeuGcGM3, percentages of binding and cytotoxicity against L1210 cells, and survival times in vaccinated NSCLC patients.
Supplementary Table 2 from Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier
Authors: Salphati Laurent , Heffron Timothy P. , Alicke Bruno , Nishimura Merry , Barck Kai , Carano Richard A. , Cheong Jonathan , Edgar Kyle A. , Greve Joan , Kharbanda Samir , Koeppen Hartmut , Lau Shari , Lee Leslie B. , Pang Jodie , Plise Emile G. , Pokorny Jenny L. , Reslan Hani Bou , Sarkaria Jann N. , Wallin Jeffrey J. , Zhang Xiaolin , Gould Stephen E. , Olivero Alan G. , Phillips Heidi S.
Published: April 2023

PDF file - 60K, Plasma Concentrations, Brain Concentrations and Brain-to-Plasma Ratio Measured at the End of Study (42 days) 2 hours Following the Last Daily PO Administration of GNE-317 (40 mg/kg), GDC-0941 (250 mg/kg) or GDC-0980 (10 mg/kg) to GS2 Tumor-Bearing Mice
Supplementary Table 1 from Cytolytic Virus Activation Therapy for Epstein-Barr Virus–Driven Tumors
Authors: Wildeman Maarten A. , Novalić Zlata , Verkuijlen Sandra A.W.M. , Juwana Hedy , Huitema Alwin D.R. , Tan I. Bing , Middeldorp Jaap M. , de Boer Jan Paul , Greijer Astrid E.
Published: April 2023

PDF file, 21K, Primers used for quantitative LightCycler PCR.
Supplementary Methods, Tables 1-2, Figures 1-4 from ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer Patients
Authors: Sveen Anita , Ågesen Trude H. , Nesbakken Arild , Meling Gunn Iren , Rognum Torleiv O. , Liestøl Knut , Skotheim Rolf I. , Lothe Ragnhild A.
Published: April 2023

PDF file - 292K, The Supplementary Material contains Supplementary Methods, Supplementary Tables S1 and S2, and Supplementary Figures S1-S4 Table S1. Genes in the prognostic expression signature Table S2. Cox proportional hazards analyses for patients in the learning series Figure S1. Cross-validated partial likelihood and number of active predictors in the learning series as a function of the penalty parameter Figure S2. Expression in the learning series of the genes in the 7-gene prognostic signature. Figure S3. Survival curves for stage III patients in the validation series. Figure S4. Survival curves for stage III patients in the validation series aged 75 years or older
Supplementary Tables 1 - 4 from Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
Authors: Griewank Klaus G. , Westekemper Henrike , Murali Rajmohan , Mach Monika , Schilling Bastian , Wiesner Thomas , Schimming Tobias , Livingstone Elisabeth , Sucker Antje , Grabellus Florian , Metz Claudia , Süsskind Daniela , Hillen Uwe , Speicher Michael R. , Woodman Scott E. , Steuhl Klaus-Peter , Schadendorf Dirk
Published: April 2023

PDF file - 108K, Supplemental Table 1. List of hotspot mutations screened Supplemental Table 2. List of potential mutations screened Supplemental Table 3. List of KIT sequencing primers Supplemental Table 4. Primers used to verify mutations
Related Article from Competing Risk Analyses: How Are They Different and Why Should You Care?
Authors: Chappell Rick
Published: April 2023

Related Article from Competing Risk Analyses: How Are They Different and Why Should You Care?
Supplementary Figure 8 from Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
Authors: Griewank Klaus G. , Westekemper Henrike , Murali Rajmohan , Mach Monika , Schilling Bastian , Wiesner Thomas , Schimming Tobias , Livingstone Elisabeth , Sucker Antje , Grabellus Florian , Metz Claudia , Süsskind Daniela , Hillen Uwe , Speicher Michael R. , Woodman Scott E. , Steuhl Klaus-Peter , Schadendorf Dirk
Published: April 2023

PDF file - 72K, Supplemental Figure 8. Individual chromosome penetrance blots of NRAS-mutant conjunctival melanomas
Supplementary Figure 6 from Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
Authors: Griewank Klaus G. , Westekemper Henrike , Murali Rajmohan , Mach Monika , Schilling Bastian , Wiesner Thomas , Schimming Tobias , Livingstone Elisabeth , Sucker Antje , Grabellus Florian , Metz Claudia , Süsskind Daniela , Hillen Uwe , Speicher Michael R. , Woodman Scott E. , Steuhl Klaus-Peter , Schadendorf Dirk
Published: April 2023

PDF file - 74K, Supplemental Figure 6. Individual chromosome penetrance blots of uveal melanomas.
Supplementary Figure 3 from Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
Authors: Griewank Klaus G. , Westekemper Henrike , Murali Rajmohan , Mach Monika , Schilling Bastian , Wiesner Thomas , Schimming Tobias , Livingstone Elisabeth , Sucker Antje , Grabellus Florian , Metz Claudia , Süsskind Daniela , Hillen Uwe , Speicher Michael R. , Woodman Scott E. , Steuhl Klaus-Peter , Schadendorf Dirk
Published: April 2023

PDF file - 502K, Supplemental Figure 3. Summary blots of individual arrays.
Supplementary Figure 3 from Decreased NK Cells in Patients with Head and Neck Cancer Determined in Archival DNA
Authors: Accomando William P. , Wiencke John K. , Houseman E. Andres , Butler Rondi A. , Zheng Shichun , Nelson Heather H. , Kelsey Karl T.
Published: April 2023

PDF file - 48K, Demethylation of a DNA region in NKp46 in control and HNSCC patient bloods assessed by qMSP
Supplementary Table 2 from ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
Authors: Biddlestone-Thorpe Laura , Sajjad Muhammad , Rosenberg Elizabeth , Beckta Jason M. , Valerie Nicholas C.K. , Tokarz Mary , Adams Bret R. , Wagner Alison F. , Khalil Ashraf , Gilfor Donna , Golding Sarah E. , Deb Sumitra , Temesi David G. , Lau Alan , O'Connor Mark J. , Choe Kevin S. , Parada Luis F. , Lim Sang Kyun , Mukhopadhyay Nitai D. , Valerie Kristoffer
Published: April 2023

PDF file - 53K, Preparation of brain slices.
Supplementary Figure 8 from ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
Authors: Biddlestone-Thorpe Laura , Sajjad Muhammad , Rosenberg Elizabeth , Beckta Jason M. , Valerie Nicholas C.K. , Tokarz Mary , Adams Bret R. , Wagner Alison F. , Khalil Ashraf , Gilfor Donna , Golding Sarah E. , Deb Sumitra , Temesi David G. , Lau Alan , O'Connor Mark J. , Choe Kevin S. , Parada Luis F. , Lim Sang Kyun , Mukhopadhyay Nitai D. , Valerie Kristoffer
Published: April 2023

PDF file - 159K, U1242 tumors with 'forced' expression of mutant p53 are more sensitive to KU-60019.